SCHEMBL4002133

SCHEMBL4002133

Cc1c(-c2cn(C)c(=O)c(Nc3ccc(N4CC[SH2]CC4=O)cc3)n2)cccc1N(C(=O)c1ccccc1)C(C)(C)O

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5243787 0.83 BTK (0.48) BTK
SCHEMBL4002941 0.80 BTK (0.44) BTK
SCHEMBL4008786 0.79 BTK (0.49) BTK
SCHEMBL5241331 0.78 BTK (0.46) BTK
SCHEMBL4008738 0.76 BTK (0.70) BTK
SCHEMBL4004426 0.76 BTK (0.58) BTK
SCHEMBL5243052 0.75 BTK (0.57) BTK
SCHEMBL5240264 0.75 BTK (0.56) BTK
SCHEMBL4010966 0.74 BTK (0.57) BTK
SCHEMBL4006158 0.74 BTK (0.61) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed